Motesanib Does Not Make a Mark in NSCLC Study

Motesanib, a drug meant for those cancers which are difficult to treat , has unfortunately not lived up to expectations in the phase III trial.

Infact, it did not make any significant contribution in improving the survival rate among victims of non-small cell lung cancer (NSCLC).

Thyroid Cancer – Symptoms - Risk Factors - Diagnosis - Treatment - Prevention
“Shaped like a butterfly she sits within the neck,” that’s what an anonymous poet wrote about the thyroid gland but it can become cancerous and spread to other parts.

Nearly 1,090 patients with advanced nonsquamous NSCLC were part of the study.

Source-Medindia

Uterine Cancer / Endometrial Cancer - Symptoms - Risk Factors – Prognosis - Treatment
Uterine Cancer or Cancer of the Uterus (or Endometrial Cancer) refer to cancers affecting the uterus or the womb in women. Learn about the different types of uterine cancer, symptoms, staging, diagnosis, prognosis, treatment, survival rates and news on uterine cancer.

Tumor Markers - For Cancer Diagnosis and Prognosis
An ideal tumor marker for a cancer should be specific to that cancer and not generate false positive results.